Новые возможности в терапии хронического миелолейкоза: дазатиниб

М. А. Волкова · Клиническая онкогематология. Фундаментальные исследования и клиническая практика · 2008

This article presents a short historical review of chemotherapy results in chronic myelocytic leukemia and the use of Dasatinib in the treatment of this disease and Ph-positive acute lymphoblastic leukemia. Mechanism of Dasatinib action, comparison of Dasatinib and Imatinib efficacy, advantages of Dasatinib in BCR-ABL mutations, side effects and complications of Dasatinib treatment are described.

Cited by 0 works.

Authors